SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-000846
Filing Date
2020-02-14
Accepted
2020-02-14 16:46:49
Documents
12
Period of Report
2020-02-12
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20200113x8k3d7e658.htm   iXBRL 8-K 31874
  Complete submission text file 0001558370-20-000846.txt   149985

Data Files

Seq Description Document Type Size
2 EX-101.SCH imgn-20200113.xsd EX-101.SCH 3037
3 EX-101.LAB imgn-20200113_lab.xml EX-101.LAB 16753
4 EX-101.PRE imgn-20200113_pre.xml EX-101.PRE 9900
10 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20200113x8k3d7e658_htm.xml XML 4646
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 20621286
SIC: 2834 Pharmaceutical Preparations